These results were further confirmed by the TUNEL assay, which showed that inhibition of mitophagy could enhance the effect of NDUFA4L2 knockdown-induced growth inhibition in GBM cells in vivo, consistent with the aforementioned in vitro results. The gene discussed is COXFA4L2; the disease is glioblastoma.